Evidence map›Paper›PMID 41664803›Full record

ArticleArchives of academic emergency medicine2025

Predicting the Risk of Opioid-induced Respiratory Depression Using ChatGPT-4o and Machine Learning Techniques.

Mohammad Meshkini, Sayed Masoud Hosseini, Peyman Erfan Talab Evini, Mitra Rahimi, Babak Mostafazadeh, Pooya Eini, Nahal Babaeian Amini, Amirhossein Faghihi, Farhad Esmailsorkh, Sajede Karimi and 10 more

Abstract read
In one paragraph

Article in Archives of academic emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Mohammad MeshkiniToxicological Research Center, Excellence Center of Clinical Toxicology, Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Sayed Masoud HosseiniToxicological Research Center, Excellence Center of Clinical Toxicology, Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Peyman Erfan Talab EviniToxicological Research Center, Excellence Center of Clinical Toxicology, Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mitra RahimiToxicological Research Center, Excellence Center of Clinical Toxicology, Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Babak MostafazadehToxicological Research Center, Excellence Center of Clinical Toxicology, Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Pooya EiniToxicological Research Center, Excellence Center of Clinical Toxicology, Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Nahal Babaeian AminiToxicological Research Center, Excellence Center of Clinical Toxicology, Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Amirhossein FaghihiToxicological Research Center, Excellence Center of Clinical Toxicology, Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Farhad EsmailsorkhToxicological Research Center, Excellence Center of Clinical Toxicology, Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Sajede KarimiToxicological Research Center, Excellence Center of Clinical Toxicology, Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammad AsadiToxicological Research Center, Excellence Center of Clinical Toxicology, Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hadi JalilvandDepartment of Epidemiology and Biostatistics, School of Health, Tabriz University of Medical Sciences, Tabriz, Iran.
Nasibeh Rady RazDepartment of Artificial Intelligence (AI) in Medicine, School of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Iman AlidadyaniDepartment of Artificial Intelligence (AI) in Medicine, School of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Hadi JafariToxicological Research Center, Excellence Center of Clinical Toxicology, Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Faraz ZandiyehToxicological Research Center, Excellence Center of Clinical Toxicology, Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Kiandokht KhorshidiToxicological Research Center, Excellence Center of Clinical Toxicology, Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Maryam AhadiToxicological Research Center, Excellence Center of Clinical Toxicology, Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Shayesteh Ashrafi-EsfahaniToxicological Research Center, Excellence Center of Clinical Toxicology, Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Shahin ShadniaToxicological Research Center, Excellence Center of Clinical Toxicology, Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Opioid-induced respiratory depression is a life-threatening complication of opioid overdose. This study aimed to develop a model for predicting the risk of respiratory depression following opioid overdose using ChatGPT-4o. Methods: A retrospective cross-sectional study was conducted on 2,005 patients admitted following opioid overdose at Loghman Hakim Hospital, Tehran, Iran, from February 2021 to February 2024. Demographic data, clinical presentations, interventions, and outcomes of patients were extracted from electronic medical records and a predictive model was developed using a no-code methodology with the assistance of ChatGPT-4o. Results: 2,005 patients with the mean age of 32.97 ± 14.86 (Range: 1-100) years were studied (74.5% male). Respiratory depression was observed in 18% of patients upon admission. Naloxone was administered to 37.6% of patients, with higher usage in those requiring intubation. Key predictors included low oxygen saturation (SpO₂), low respiratory rate (RR), and increased heart rate (HR). The predictive model achieved an accuracy of 94.4% (95% confidence interval (CI): 87.0-96.3), a recall of 81.0% (95% CI: 78.0-84.0) for respiratory depression, and an area under the curve (AUC) of 0.98 (95% CI: 0.95-0.99). Conclusion: The study highlights critical clinical predictors of respiratory depression risk in opioid overdose patients and demonstrates the potential of machine learning models in enhancing early detection and intervention.

Indexed as

Generative Artificial IntelligenceMachine learningOpiate overdosePrecision MedicineRespiratory insufficiency

Identifiers

PMID41664803
PMCPMC12883042

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.